Financials Aclarion, Inc.

Equities

ACON

US6551872012

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
0.2766 USD -7.74% Intraday chart for Aclarion, Inc. -5.31% -91.36%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 4.536 1.759 2.269 -
Enterprise Value (EV) 1 4.536 1.759 2.269 2.269
P/E ratio -0.44 x - -0.24 x -0.53 x
Yield - - - -
Capitalization / Revenue 75.1 x 23.3 x 29.1 x -
EV / Revenue 75.1 x 23.3 x 29.1 x -
EV / EBITDA - - - -
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - - -
Nbr of stocks (in thousands) 489 550 8,204 -
Reference price 2 9.280 3.200 0.2766 0.2766
Announcement Date 2/27/23 2/21/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales 1 - 0.0604 0.0754 0.078 -
EBITDA - - - - -
EBIT 1 - -6.099 -4.876 -5.01 -
Operating Margin - -10,090.21% -6,466.82% -6,423.08% -
Earnings before Tax (EBT) 1 - -7.606 -4.911 -5.91 -5.169
Net income 1 -4.95 -7.606 -4.911 -5.91 -5.169
Net margin - -12,583.62% -6,513.75% -7,576.92% -
EPS 2 -14.08 -20.96 - -1.140 -0.5200
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/4/22 2/27/23 2/21/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 0.0107 0.0182 0.0225 0.0255 0.0171 - - - - -
EBITDA - - - - - - - - - -
EBIT -2.365 -1.633 -1.327 -1.181 -1.406 - - - - -
Operating Margin -22,147.94% -8,964.11% -5,891.47% -4,637.85% -8,237.84% - - - - -
Earnings before Tax (EBT) 1 -3.708 -1.633 -1.329 -1.183 -1.465 - -1.708 -1.542 -1.412 -1.248
Net income 1 -3.836 -1.633 -1.329 -1.183 -1.465 -0.998 -1.708 -1.542 -1.412 -1.248
Net margin -35,914.98% -8,962.84% -5,901.02% -4,646.49% -8,579.73% - - - - -
EPS 2 -7.840 -3.360 -1.600 -2.400 -2.880 -1.920 -0.5700 -0.2100 -0.1900 -0.1700
Dividend per Share - - - - - - - - - -
Announcement Date 8/15/22 11/14/22 2/27/23 7/3/23 8/25/23 11/14/23 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 3/4/22 2/27/23 2/21/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.2766 USD
Average target price
1.5 USD
Spread / Average Target
+442.30%
Consensus
  1. Stock Market
  2. Equities
  3. ACON Stock
  4. Financials Aclarion, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW